Back to Authors

Riad, Samy

Mayo Clinic

Mayo Clinic

Citations 3

415.4: Real-world use of hypothermic machine perfusion: Trends and impact on short-term kidney allograft outcomes.
Cortez, Alexander, Tapia, Amanda, Benavides Lopez, Xiomara, Liang, Yun, Ryan, Randi , Nguyen, Michelle, Riad, Samy, Benavides, Xiomara , Ryan, Randi J. , Riad, Samy

Transplantation | August 31, 2026 | Volume: 110 | Issue: 9S | Pages: No page available

10.1097/01.tp.0001251832.60643.8d Get It

Delayed graft function and long-term outcomes after deceased donor kidney transplantation: insights from mate-kidney analysis
Valencia, Oscar A. Garcia, Alrifai, Ahmed, Mahgoub, Mohammed, Mour, Girish, Smith, Byron, Bentall, Andrew J., Issa, Naim , Riad, Samy, Garcia Valencia, Oscar A, Alrifai, Ahmed Zeen Alabedeen, Mahgoub, Mohammed Y, Issa, Naim S, Cortez, Alexander R. , Valencia, Oscar A. Garcia , Mour, Girish , Bentall, Andrew , Jadlowiec, Caroline C. , Amer, Hatem , Riad, Samy

Transplant International | June 16, 2026 | Volume: 39 | Issue: No issue available | Pages: No page available

10.3389/ti.2026.16526 Get It

Delayed graft function (DGF) is a frequent complication after deceased donor kidney transplantation, yet its long-term impact remains understudied. Heterogeneous populations, short follow-up, and inadequate control of donor-related factors have limited prior studies. Using the Scientific Registry of Transplant Recipients (2005–2024), we evaluated the association between DGF and long-term graft outcomes, including a mate-kidney (same donor, discordant DGF status) analysis to isolate its independent effect. We identified 103,678 dialysis-dependent deceased donor kidney recipients maintained on tacrolimus and mycophenolate. Mixed-effects Cox models, adjusted for donor, recipient, immunologic, and procurement factors. DGF occurred in 30.1% of recipients and was associated with increased death-censored graft failure (HR 1.40; 95% CI 1.33–1.47) and overall graft failure (HR 1.27; 95% CI 1.23–1.31). DGF recipients had higher rejection rates at 6 (6.0% vs. 4.7%) and 12 months (8.9% vs. 7.3%), longer hospital stay, and higher 1-year rehospitalization. In the mate-kidney analysis (6,818 donors), DGF remained strongly associated with death-censored graft failure (HR 1.58; 95% CI 1.39–1.80) and overall graft failure (HR 1.35; 95% CI 1.25–1.46), confirming the independent effect of DGF. DGF is a strong predictor of adverse long-term outcomes irrespective of rejection and warrants targeted prevention strategies and intensified follow-up.